DRMA Award Disclosure
Van Hoose Kyri K. · SEC Form 4 · Filed Aug 18, 2026
Award
Reported value range
Not reported
Van Hoose Kyri K. SVP, CFO
DRMA
Transaction date
Aug 16, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed 2 days later
DRMA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series F Warrant (Right to Buy) on Common Stock
- Quantity / price
- 102,040 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-039046
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dermata Therapeutics, Inc. DRMA | Award | Aug 16, 2026 | Not reported |
| Dermata Therapeutics, Inc. DRMA | Award | Aug 16, 2026 | Not reported |
| Dermata Therapeutics, Inc. DRMA Current | Award | Aug 16, 2026 | Not reported |